verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: avkare
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler avkare
Dosage Form TABLET
Routes
ORAL
Active Ingredients

verapamil hydrochloride 120 mg/1

Manufacturer
AvKARE

Identifiers & Regulatory

Product NDC 42291-855
Product ID 42291-855_4875cced-75af-ed7f-e063-6294a90addfa
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA071881
Listing Expiration 2027-12-31
Marketing Start 2020-04-13

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42291855
Hyphenated Format 42291-855

Supplemental Identifiers

RxCUI
897666 897683 897722
UNII
V3888OEY5R

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA071881 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 120 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (42291-855-01)
source: ndc

Packages (1)

42291-855-01 100 TABLET in 1 BOTTLE (42291-855-01)

Ingredients (1)

verapamil hydrochloride (120 mg/1)

Linked Drug Pages (1)

VERAPAMIL HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4875cced-75af-ed7f-e063-6294a90addfa", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897666", "897683", "897722"], "spl_set_id": ["a32f346e-71cf-cc11-e053-2a95a90ae88c"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (42291-855-01)", "package_ndc": "42291-855-01", "marketing_start_date": "20200413"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "42291-855_4875cced-75af-ed7f-e063-6294a90addfa", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "42291-855", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA071881", "marketing_category": "ANDA", "marketing_start_date": "20200413", "listing_expiration_date": "20271231"}